Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs
- PMID: 1310443
- DOI: 10.1161/01.res.70.2.223
Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs
Abstract
Single or multiple brief periods of ischemia (preconditioning) have been shown to protect the myocardium from infarction after a subsequent more prolonged ischemic insult. To test the hypothesis that preconditioning is the result of opening ATP-sensitive potassium (KATP) channels, a selective KATP channel antagonist, glibenclamide, was administered before or immediately after preconditioning in barbital-anesthetized open-chest dogs subjected to 60 minutes of left circumflex coronary artery (LCX) occlusion followed by 5 hours of reperfusion. Preconditioning was elicited by 5 minutes of LCX occlusion followed by 10 minutes of reperfusion before the 60-minute occlusion period. Glibenclamide (0.3 mg/kg i.v.) or vehicle was given 10 minutes before the initial ischemic insult in each of four groups. In a fifth group, glibenclamide was administered immediately after preconditioning. In a final series (group 6), a selective potassium channel opener, RP 52891 (10 micrograms/kg bolus and 0.1 micrograms/mg/min i.v.) was started 10 minutes before occlusion and continued throughout reperfusion. Transmural myocardial blood flow was measured at 30 minutes of occlusion, and infarct size was determined by triphenyltetrazolium staining and expressed as a percent of the area at risk. There were no significant differences in hemodynamics, collateral blood flow, or area at risk between groups. The ratio of infarct size to area at risk in the control group (28 +/- 6%) was not different from the group pretreated with glibenclamide in the absence of preconditioning (31 +/- 6%). Preconditioning produced a marked reduction (p less than 0.002) in infarct size (28 +/- 6% to 6 +/- 2%), whereas glibenclamide administered before or immediately after preconditioning completely abolished the protective effect (28 +/- 6% and 30 +/- 8%, respectively). RP 52891 also produced a significant (p less than 0.03) reduction (28 +/- 6% to 13 +/- 3%) in infarct size. These results suggest that myocardial preconditioning in the canine heart is mediated by activation of KATP channels and that these channels may serve an endogenous myocardial protective role.
Similar articles
-
Bimakalim, an ATP-sensitive potassium channel opener, mimics the effects of ischemic preconditioning to reduce infarct size, adenosine release, and neutrophil function in dogs.Circulation. 1995 Sep 1;92(5):1236-45. doi: 10.1161/01.cir.92.5.1236. Circulation. 1995. PMID: 7648671
-
A comparison of adenosine-induced cardioprotection and ischemic preconditioning in dogs. Efficacy, time course, and role of KATP channels.Circulation. 1994 Mar;89(3):1229-36. doi: 10.1161/01.cir.89.3.1229. Circulation. 1994. PMID: 8124811
-
Effects of the KATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs.Circulation. 1994 Apr;89(4):1769-75. doi: 10.1161/01.cir.89.4.1769. Circulation. 1994. PMID: 8149542
-
Glibenclamide action on myocardial function and arrhythmia incidence in the healthy and diabetic heart.Cardiovasc Hematol Agents Med Chem. 2007 Jan;5(1):43-53. doi: 10.2174/187152507779315868. Cardiovasc Hematol Agents Med Chem. 2007. PMID: 17266547 Review.
-
ATP-sensitive potassium channels and myocardial preconditioning.Basic Res Cardiol. 1995 Mar-Apr;90(2):85-8. doi: 10.1007/BF00789438. Basic Res Cardiol. 1995. PMID: 7646421 Review.
Cited by
-
Plasticity of sarcolemmal KATP channel surface expression: relevance during ischemia and ischemic preconditioning.Am J Physiol Heart Circ Physiol. 2016 Jun 1;310(11):H1558-66. doi: 10.1152/ajpheart.00158.2016. Epub 2016 Apr 1. Am J Physiol Heart Circ Physiol. 2016. PMID: 27037371 Free PMC article.
-
Effects of glibenclamide, a K(ATP) channel blocker, on warm-up phenomenon in type II diabetic patients with chronic stable angina pectoris.Clin Cardiol. 2000 Jul;23(7):535-9. doi: 10.1002/clc.4960230713. Clin Cardiol. 2000. PMID: 10894443 Free PMC article.
-
Glycaemic Control in Patients Undergoing Percutaneous Coronary Intervention: What Is the Role for the Novel Antidiabetic Agents? A Comprehensive Review of Basic Science and Clinical Data.Int J Mol Sci. 2022 Jun 30;23(13):7261. doi: 10.3390/ijms23137261. Int J Mol Sci. 2022. PMID: 35806265 Free PMC article. Review.
-
Limitation of infarct size with preconditioning and calcium antagonist (diltiazem): difference in 99mTc-PYP uptake in the myocardium.Ann Nucl Med. 1996 May;10(2):201-9. doi: 10.1007/BF03165393. Ann Nucl Med. 1996. PMID: 8800449
-
Ischemic preconditioning in isolated perfused mouse heart: reduction in infarct size without improvement of post-ischemic ventricular function.Mol Cell Biochem. 1998 Sep;186(1-2):69-77. Mol Cell Biochem. 1998. PMID: 9774187
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical